New Leader Set to Propel Global Expansion and Technology Innovation
CAMPBELL, Calif., March 4, 2025 /PRNewswire/ -- Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its comprehensive development traceability platform, today announced the appointment of Nader Fathi as Chief Executive Officer. Nader brings over 30 years of unparalleled experience driving business growth, building strategic partnerships, and leading digital transformation across high-tech and medical device industries. The appointment of the new CEO follows Enlil's strong momentum across the MedTech ecosystem, spanning OEMs, incubators, contract manufacturers, product designers, developers, and regulatory consultants.
Nader will harness his deep expertise in AI, BI, manufacturing, and IoT cloud solutions to fuel technology innovation and accelerate Enlil's global growth. With seven technology patents and a history of building successful technology companies, Nader is ready to elevate Enlil into a global leader in regulated product development technology.
"As CEO, Nader will focus on expanding Enlil's investor network, accelerating sales, and strengthening its market position," said Amr Salahieh, Founder of Shifamed and Enlil Chairman. "He is committed to securing long-term funding and strategic partnerships to fuel growth while strengthening sales efforts to expand Enlil's solutions to a wider global audience."
Nader's deep-rooted connections within the global high-tech ecosystem position him as the ideal leader to bridge Enlil's transformative platform with companies struggling with fragmented technology to streamline product development, ensure regulatory compliance, and enhance operational efficiency. His Executive-in-Residence role at Plug and Play Ventures and USC Viterbi Computer Science Advisory Board further enhances his ability to identify and capitalize on emerging trends.
As a serial entrepreneur, Nader has successfully scaled companies from startups to industry leaders. In his most recent role as co-founder and CEO of Kiana Analytics, he established strategic partnerships with global giants like HPE, Honeywell, Google, and Cisco to secure blue-chip customers in the MedTech, manufacturing, and energy sectors. His leadership prowess extends to successful startup exits, including the acquisition of SigmaQuest by Siemens/Camstar, where he later expanded BI and analytics solutions in the manufacturing sector.
Enlil seamlessly integrates Requirements Management, QMS, PLM, MES, ERP, and more, creating an end-to-end digital thread that powers innovation and compliance from ideation to commercialization. The platform provides a foundation for the entire regulated product ecosystem to navigate complex product lifecycles and regulatory landscapes with agility, real-time collaboration, and efficiency.
"I'm thrilled to join Enlil at such a pivotal moment," said Nader. "The opportunity to lead a company transforming regulated product development is incredibly exciting. Enlil's solution, built in collaboration with Shifamed portfolio companies aiming to accelerate their time to FDA approval, has proven its value in real-world scenarios. Supported by the superbly competent Enlil team, I will focus on driving sustained growth, expanding our global footprint, and establishing Enlil as the go-to platform for innovative companies striving to bring life-changing regulated products to market."
About Enlil
Enlil, Inc., a Shifamed portfolio company, emerged to address the fragmented nature of MedTech innovation. Its scalable, cloud-based development traceability platform is a unified source of truth across the entire product development lifecycle. It provides digital traceability, compliance, development and manufacturing efficiency, and actionable insights. With an innovation hub pedigree and a bold vision for AI enablement, Enlil empowers companies across the regulated product ecosystem to innovate faster, smarter, and with unwavering regulatory confidence.
For more information, visit enlil.com.
About Shifamed
Founded by serial entrepreneur Amr Salahieh, Shifamed is a highly specialized medical innovation hub focused on developing solutions that accelerate time to market, reduce risk, increase impact, and forge a path toward a world where patients lead longer healthier lives.
To learn more about Shifamed, please visit shifamed.com.
MEDIA CONTACT:
Christine Pearsall
Director of Marketing, Enlil, Inc.
[email protected]
SOURCE Enlil, Inc.
Share this article